Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00277-015-2577-7.pdf
Reference21 articles.
1. Pui C-H, Mullighan CG, Evans WE, Relling MV (2012) Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 120:1165–1174
2. Ko RH, Ji L, Barnette P et al (2010) Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. Journal of Clinical Oncology 28:648–654
3. Schrappe M, Hunger SP, Pui CH et al (2012) Outcomes after induction failure in childhood acute lymphoblastic leukemia. New England Journal of Medicine 366:1371–1381
4. Hijiya N, Barry E, Arceci RJ (2012) Clofarabine in pediatric acute leukemia: current findings and issues. Pediatr Blood Cancer 59:417–422
5. Bonate PL, Arthaud L, Cantrell WR Jr et al (2006) Discovery and development of clofarabine: a nucleoside analogue for treating cancer. Nat Rev Drug Discov 5:855–863
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic Leukemia;Advances in Therapy;2023-10-11
2. Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2022-02
3. Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis;Annals of Hematology;2021-08-06
4. CD4+ cells as a potential biomarker for cytomegalovirus retinitis in children with acute lymphocytic leukemia;Chinese Medical Journal;2019-02-05
5. A Multicenter Retrospective Analysis on the Treatment Pattern and Outcome in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia;Clinical Pediatric Hematology-Oncology;2017-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3